• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX VAGINAL PANEL; VAGINITIS & BACTERIAL VAGINOSIS NUCLEIC ACID DETECTION SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS) BD MAX VAGINAL PANEL; VAGINITIS & BACTERIAL VAGINOSIS NUCLEIC ACID DETECTION SYSTEM Back to Search Results
Model Number 443712
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/04/2021
Event Type  malfunction  
Manufacturer Narrative
Medical device expiration date: unknown a device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.Device manufacture date: unknown (b)(4).
 
Event Description
It was reported while testing with bd max¿ vaginal panel a (b)(6) for trichomonas was obtained.Sample was repeated and result was negative.Reported as negative.
 
Event Description
It was reported while testing with bd max¿ vaginal panel a false positive for trichomonas was obtained.Sample was repeated and result was negative.Reported as negative.
 
Manufacturer Narrative
The following fields were updated due to additional information: d.4.Medical device lot #: 0259582 d.4.Medical device expiration date: 9/15/2021 h.4.Device manufacture date: 9/15/2020 h.6.Investigation: the complaint investigation for discrepant results with the bd max vaginal panel (ref 443712) lot 0259582 was performed by the review of the manufacturing records, customer¿s data analysis and verification of complaints history.Initially, customer did not provide kit lot number but analysis of the customer data revealed that bd max¿ vaginal panel kit lot 0259582 was used to test the sample.Review of the manufacturing records of bd max vaginal panel indicated that lot 0259582 was manufactured according to specifications and met performance requirements.Customer reported a discrepant result for a patient sample for the cgla and tv targets while using the bd max¿ vaginal panel and provided two databases from instruments ct1266 and ct1364 for investigation.Database analysis allowed to identify discrepant results in 3 runs (runs 3297 and 3298 on ct1266 and run 1249 on ct1364).The sample was initially tested in run 3297(position a3), and gave an unresolve (unr) results for all targets, which could be linked with specimen-associated interfering/ inhibiting substance.The same sample buffer tube was repeated in run 3298 position a8, as mentioned in the complaint text, and gave cgla and tv positive results.When the same sample buffer tube was repeated in run 1249, on instrument ct1364 with another kit lot (0259581), all the targets gave a negative result.However, retest of the same sample buffer tube three times is an off-label use of the bd max¿ vaginal assay.Manual pcr curve adjudication was performed on the sample in run 3298 position a8.Manual curve adjudication has limitations; visual examination of pcr curves for low signal and/or aberrant curve geometry is an extremely conservative assessment of the data.Analysis of the pcr curve of run 3297 shows a step dislocation in the raw pcr signal of every channels and generated positive tv and cgla results.However, it is unlikely that those step dislocations are due to true amplification but a root cause for those discrepant results could not be identified.There is no indication of an increase in complaints for discrepant results for bd max vaginal panel lot 0259582.The root cause was not identified.Bd cannot confirm the complaint based on the investigation that was performed.H3 other text : see h.10.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD MAX VAGINAL PANEL
Type of Device
VAGINITIS & BACTERIAL VAGINOSIS NUCLEIC ACID DETECTION SYSTEM
Manufacturer (Section D)
GENEOHM SCIENCES CANADA, INC. (BD DIAGNOSTICS)
2555 blv. du parc techn
quebec
MDR Report Key11374580
MDR Text Key247509318
Report Number3007420875-2021-00005
Device Sequence Number1
Product Code PQA
UDI-Device Identifier00382904437121
UDI-Public00382904437121
Combination Product (y/n)N
PMA/PMN Number
DEN160001
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type other,user facility
Type of Report Initial,Followup
Report Date 06/02/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date09/15/2021
Device Model Number443712
Device Catalogue Number443712
Device Lot Number0259582
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 02/04/2021
Initial Date FDA Received02/24/2021
Supplement Dates Manufacturer Received06/02/2021
Supplement Dates FDA Received06/14/2021
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-